New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
09:45 EDTMYLMylan moves higher, levels to watch
Abbott (ABT) sold its developed markets generics pharmaceuticals business to Mylan (MYL), which is sending shares of the latter higher to $51.83. At that price next resistance is at $53, the session high. Support is at $50.88.
News For MYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 23, 2015
07:16 EDTMYLMylan signs exclusive agreement with Gilead to distribute Solvaldi, Harvoni
Subscribe for More Information
February 20, 2015
07:08 EDTMYLAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 18, 2015
08:41 EDTMYLThe Medicines Co. says not giving financial guidance due to Hospira suit
Subscribe for More Information
February 17, 2015
18:06 EDTMYLPaulson & Co gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use